Delivery Order SPE2DB20D3101-SPE2DB25FRLA9

Award Date 5/22/25
Potential Completion Date 5/23/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product, with a ceiling value of $13,281.77 and a period of performance through April 28, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of RYTARY ER 23.75 MG-95 MG CAP 100S, a specialty medication. The contract has a ceiling value of $2,142.00 and a completion date of August 6, 2024. It is a firm-fixed-price contract, indicating a set price for the delivered items. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,195.01, is for the delivery of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of June 26, 2024. This award is not associated with a set-aside program. AmerisourceBergen Drug...
This is a $9,682.03 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the pharmaceutical product RYTARY ER 23.75 MG-95 MG CAP 100S. There is no set-aside designation, indicating open competition for the award. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order award to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,325.53 firm fixed-price contract is for the supply of RYTARY ER 23.75 MG-95 MG CAP 100S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product, with a ceiling value of $7,625.89. The contract has an ultimate completion date of March 6, 2025 and is a Firm Fixed Price Delivery Order. This award is not associated with any set-aside program. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product, with a ceiling value of $6,625.52 and a delivery completion date of November 7, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $4,807.37, is for the delivery of RYTARY ER 23.75 MG-95 MG CAP 100S, a prescription medication. The contract is a Delivery Order under a Firm Fixed Price pricing type, with a completion date of March 14, 2025. The contract was awarded on March 13, 2025 and does not have a set-aside designation,...
This is a Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of RYTARY ER 61.25 MG-245 MG CAP 100S, a pharmaceutical product, with a ceiling value of $1,256.40 and an ultimate completion date of June 17, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product, with a ceiling value of $3,906.14. The contract has a performance period through June 12, 2024 and is a firm fixed-price type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRLA9
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of RYTARY ER 23.75 MG-95 MG CAP 100S, a pharmaceutical product, with a ceiling value of $1,109.48. The contract is a Firm Fixed Price type, with a performance period ending on May 23, 2025. This award is not a set-aside and was competitively awarded. AmerisourceBergen Drug Corp is the prime contractor and there are no subcontractors mentioned. The DLA is the funding agency, and this delivery order is likely part of the company's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to military healthcare programs.

Generated 8/21/25, 9:43 AM